image
Oncternal Therapeutics, Inc. ONCT
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 1.14
2.7 %
$ 3.37 M
Market Cap
-0.1
P/E
BALANCE SHEET
36.7 M ASSETS
-46.50%
Growth Rates
1Year -46.50%
3Years -32.38%
5Years 3.24%
7Years 5.95%
10Years 8.94%
6.68 M LIABILITIES
-13.08%
Growth Rates
1Year -13.08%
3Years 4.46%
5Years 5.09%
7Years 5.43%
10Years 3.10%
30.1 M EQUITY
118.98%
Growth Rates
1Year 118.98%
3Years 33.19%
5Years 2.85%
7Years 6.07%
10Years 10.90%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Oncternal Therapeutics, Inc.
image
Current Assets 36.1 M
Cash & Short-Term Investments 34.3 M
Receivables 632 K
Other Current Assets 1.17 M
Non-Current Assets 670 K
Long-Term Investments 0
PP&E 258 K
Other Non-Current Assets 412 K
Current Liabilities 5.2 M
Accounts Payable 1.15 M
Short-Term Debt 173 K
Other Current Liabilities 3.88 M
Non-Current Liabilities 1.48 M
Long-Term Debt 145 K
Other Non-Current Liabilities 1.33 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999
ASSETS
Cash & Cash Equivalents 6.7 37.1 90.8 116.7 20.1 28.3 15.8 8.9 14.1 17.9 14.5 48.0 63.7 58.2 40.2 95.5 100.2 119.5 74.0 64.5 14.8 8.9 8.8 2.7 1.5
Short Term Investments 27.6 26.6 0 0 0 0.2 28.1 13.0 15.2 31.4 0.2 8.0 10.7 0.5 8.8 2.2 9.8 0 0 0 0 0 0 0 0
Receivables 0.6 0.2 0.9 0 0 0 0 0 0 0 0 9 K 1.0 0.7 0.6 1.3 40.8 61 K 0.2 0 (0.3) 0 0 0 0
Inventory 0 0.1 (0.9) 0 0 0 0 0 0 0 0 0 0.2 0.2 0.1 92 K 78 K 0.2 0.1 0.4 0.2 0 0 0 0
Other Current Assets 1.2 3.4 1.5 2.5 1.5 2.8 2.8 4.9 5.3 1.7 0.9 1.4 1.3 1.8 0.9 1.0 1.4 3.8 1.7 1.2 0.3 41 K 0 0 0
Total Current Assets 36.1 67.3 92.9 118.0 20.8 31.2 46.1 24.3 31.9 50.2 15.2 56.8 76.8 60.4 50.7 100.0 152.3 121.7 76.0 66.2 15.0 9.0 8.8 2.7 1.5
PP&E 0.3 87 K 75 K 40 K 0.2 19 K 51 K 81 K 5 K 29 K 0.1 0.5 1.1 2.0 3.3 4.0 2.3 1.4 1.7 1.5 0.8 1.1 0 0 0
Intangible Assets 0 0 0 0 0 94 K 0.1 0.1 0.1 0.5 0.3 0.5 1.9 1.9 3.8 4.1 4.4 4.7 5.0 4.9 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 (1.6) 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 0.4 1.3 0.7 0.8 0.8 0 0 0 0 0 0 0 0 0 0 4 K 0.7 1.4 83 K 0.5 1.5 0 0 0 0
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1 3.2 1.7
Total Assets 36.7 68.7 93.6 118.8 21.7 31.3 46.2 24.5 32.0 50.7 15.6 57.8 78.2 64.2 57.7 108.1 159.7 129.3 82.8 73.1 17.3 10.0 10.1 3.2 1.7
LIABILITIES
Accounts Payable 1.1 2.9 2.0 1.1 0.9 3.3 2.6 1.2 0.4 0.5 0.8 1.7 1.2 0.8 1.3 2.8 1.6 1.3 1.4 0.9 0.5 0.6 0 0 0
Short Term Debt 0.2 87 K 75 K 40 K 0.2 0 0 0 0 0 0 7 K 82 K 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Liabilities 3.9 4.7 3.4 3.0 2.6 1.9 5.4 3.4 29.8 32.3 3.8 7.8 4.8 3.1 4.7 6.7 6.8 3.1 3.2 2.6 1.8 0.7 0 0 0
Total Current Liabilities 5.2 7.7 5.5 5.9 7.3 5.2 8.0 4.6 30.2 32.8 4.6 9.5 6.1 5.3 16.0 21.0 19.3 10.3 6.0 4.9 2.2 1.3 0 0 0
Long Term Debt 0.1 0 0 0 91 K 0 0 0 0 0 0 0 0 0 0 0 10 K 15 K 20 K 24 K 0 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (61.2) (21.6) (3.0) (4.3) 0 0 0 0 0
Other Liabilities 1.3 0 0 0 0 0 0 0 0 30 K 0.4 0.6 0.2 0.5 0.6 0.4 0.2 0.3 0.3 0 165.3 64.0 0 0 0
Total Liabilities 6.7 7.7 5.5 5.9 7.4 5.2 8.0 4.6 30.2 32.8 4.9 10.1 6.3 12.5 66.5 76.1 80.8 32.2 9.2 9.2 167.5 65.3 44.2 28.4 1.7
EQUITY
Common Stock 3 K 57 K 49 K 49 K 15 K 24 K 22 K 16 K 0.1 0.1 63 K 63 K 63 K 52 K 36 K 36 K 36 K 35 K 31 K 25 K 8 K 8 K 0 0 0
Retained Earnings (197.8) (158.3) (114.1) (82.8) (65.6) (600.1) (561.6) (531.2) (513.5) (494.8) (455.4) (413.2) (386.2) (352.9) (368.2) (321.9) (270.1) (229.8) (194.3) (157.4) (151.8) (56.3) (35.0) (26.1) (0.9)
Other Accumulative Comprehensive Income/Loss 3 K 9 K 0 0 0 (2.6) (2.7) (2.6) (2.8) (3.7) (3.7) (8.8) (8.1) (7.1) (6.5) (5.1) (3.8) (2.7) (1.7) (2.7) (3.5) 0 0 0 0
Total Equity 30.1 (158.3) (114.1) (82.8) 14.3 26.1 38.3 19.9 1.9 17.8 10.7 47.7 71.9 51.7 (8.8) 32.0 78.9 97.0 73.6 63.9 (150.2) (55.3) (34.1) (25.2) 21 K
Total Liabilities and Equity 36.7 68.7 (108.7) (76.9) 21.7 31.3 46.2 24.5 32.0 50.7 15.6 57.8 78.2 64.2 57.7 108.1 159.7 129.3 82.8 73.1 17.3 10.0 10.1 3.2 1.7
SHARES OUTSTANDING
Common Shares Outstanding 2.9 2.6 2.5 1.0 0.5 3.3 2.5 2.1 2.0 1.2 0.9 0.9 0.8 0.6 0.5 0.5 0.5 0.4 0.4 0.3 0.1 0.1 0.1 0.1 0.1